ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.034,63
1,36%
S&P 500
5.770,20
0,55%
US Dollar vs BRL
5,8165
0,49%
Bitcoin
81.457,43
-7,43%
Brent Oil
70,11
0,55%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. BioRestorative Therapies Inc (BRTX)

  7. BioRestorative Therapies Inc (BRTX) Notícias

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BRTX
DataHoraFonteTítuloCódigoCompanhia
28/02/202509:57Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
27/02/202511:45GlobeNewswire Inc.BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic PainNASDAQ:BRTXBioRestorative Therapies Inc
26/02/202522:15GlobeNewswire Inc.BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline UpdateNASDAQ:BRTXBioRestorative Therapies Inc
25/02/202510:00GlobeNewswire Inc.BioRestorative to Provide a Positive FDA Update on Clinical PipelineNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202510:30GlobeNewswire Inc.BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
19/02/202518:43Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
19/02/202518:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202510:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202509:00GlobeNewswire Inc.BRTX-100 Front and Center at ORS 2025NASDAQ:BRTXBioRestorative Therapies Inc
05/12/202408:45GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
13/11/202409:00GlobeNewswire Inc.BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical DataNASDAQ:BRTXBioRestorative Therapies Inc
12/11/202418:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BRTXBioRestorative Therapies Inc
12/11/202418:05GlobeNewswire Inc.BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
06/11/202418:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202418:25Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202409:00GlobeNewswire Inc.BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumNASDAQ:BRTXBioRestorative Therapies Inc
05/11/202409:10GlobeNewswire Inc.BioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthNASDAQ:BRTXBioRestorative Therapies Inc
31/10/202408:00GlobeNewswire Inc.BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
10/10/202408:00GlobeNewswire Inc.BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor EventsNASDAQ:BRTXBioRestorative Therapies Inc
03/10/202417:15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
19/09/202407:55GlobeNewswire Inc.BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 DrugsNASDAQ:BRTXBioRestorative Therapies Inc
13/08/202417:05GlobeNewswire Inc.BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
08/08/202417:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BRTXBioRestorative Therapies Inc
06/08/202417:05GlobeNewswire Inc.BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024NASDAQ:BRTXBioRestorative Therapies Inc
23/07/202408:10GlobeNewswire Inc.BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational MedicineNASDAQ:BRTXBioRestorative Therapies Inc
27/06/202408:40GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
17/06/202408:05GlobeNewswire Inc.BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial ResultsNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202412:40AllPennyStocks.comShares of Biotech MicroCap Rip on Licensing TalksNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202408:00GlobeNewswire Inc.BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
04/06/202409:50GlobeNewswire Inc.BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BRTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios